Pórszász, RóbertAoki, Ryo2022-08-292022-08-292021-09-17http://hdl.handle.net/2437/336890This article reviews the developing pharmacotherapy for COVID-19, especially the medications that haven't been proved to be effective but are currently undergoing multiple clinical trials. Pharmacological agents focused in this article are favipiravir, interferon beta, IL-1 inhibitors (anakinra and canakinumab), and ivermectin.43enCOVID-19SARS-CoV-2FavipiravirInterferon betaIvermectinAnakinraCanakinumabDEENK Témalista::Orvostudomány